J. Halpern

Interaction between Posaconazole and Caspofungin in Concomitant Treatment of Mice with Systemic Aspergillus Infection

D. Loebenberg, A. Cacciapuoti, J. Halpern, 2006, Antimicrobial Agents and Chemotherapy.

Cytokine Networking in Lungs of Immunocompetent Mice in Response to Inhaled Aspergillus fumigatus

J. Brieland, Craig Jackson, D. Loebenberg, 2001, Infection and Immunity.

David Aspergillus fumigatus Inhaled Immunocompetent Mice in Response to Cytokine Networking in Lungs of

R. Kastelein, J. Brieland, Craig Jackson, 2000 .

Activity of Posaconazole Combined with Amphotericin B against Aspergillus flavus Infection in Mice: Comparative Studies in Two Laboratories

Steve A. Hernandez, D. Loebenberg, F. Menzel, 2004, Antimicrobial Agents and Chemotherapy.

In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, againstAspergillus and Candida

D. Loebenberg, F. Menzel, A. Cacciapuoti, 2000, Antimicrobial Agents and Chemotherapy.

Interaction between Posaconazole and Amphotericin B in Concomitant Treatment against Candida albicans In Vivo

D. Loebenberg, A. Cacciapuoti, J. Halpern, 2005, Antimicrobial Agents and Chemotherapy.

Effect of Granulocyte Colony-Stimulating Factor Combination Therapy on Efficacy of Posaconazole (SCH56592) in an Inhalation Model of Murine Pulmonary Aspergillosis

J. Brieland, Craig Jackson, D. Loebenberg, 2004, Antimicrobial Agents and Chemotherapy.